Financials
Income statement
Fiscal date | Nov 2024 | Aug 2024 | Feb 2024 | Nov 2023 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 2.6K | 2.1K | 68.2K | 38.2K |
Selling general and admin | 48.5K | 64.2K | 203.9K | 225.6K |
Other operating expenses | 24.8K | 5.8K | 76.8K | 13.3K |
Operating income | -75.9K | -72.2K | -879.9K | -277.1K |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.6K | 3.3K | — | 0 |
Other income expense | — | 5K | — | — |
Pretax income | -77.5K | -70.5K | -751.8K | -277.1K |
Tax provision | — | — | — | — |
Net income | -77.5K | -70.5K | -751.8K | -277.1K |
Basic EPS | 0 | 0.0 | — | 0.0 |
Diluted EPS | 0 | 0.0 | — | 0.0 |
Basic average shares | 41.3M | 37.7M | — | 30.0M |
Diluted average shares | 41.3M | 37.7M | — | 30.0M |
EBITDA | -75.9K | -72.2K | -762.9K | -277.1K |
Net income from continuing op. | -77.5K | — | -751.8K | -277.1K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |